|
Health policy and outcome research
Citations 431-440 of 643 total displayed.
|
Past content
(since Jan 1999):
|
- Editorials
Economics of Sirolimus-Eluting Stents: Drug-Eluting Stents Have Really Arrived
- William S. Weintraub
Circulation 2004;110:472-474, doi:10.1161/01.CIR.0000136820.77558.B1
[Full text]
- Coronary Heart Disease
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial
- David J. Cohen, Ameet Bakhai, Chunxue Shi, Louise Githiora, Tara Lavelle, Ronna H. Berezin, Martin B. Leon, Jeffrey W. Moses, Joseph P. Carrozza, Jr, James P. Zidar, Richard E. Kuntz on behalf of the SIRIUS Investigators
Circulation 2004;110:508-514; published online before print as doi:10.1161/01.CIR.0000136821.99814.43
[Abstract]
[Full text]
- Articles
National Patterns of Use and Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Older Patients With Heart Failure and Left Ventricular Systolic Dysfunction
- Frederick A. Masoudi, Saif S. Rathore, Yongfei Wang, Edward P. Havranek, Jeptha P. Curtis, JoAnne Micale Foody, and Harlan M. Krumholz
Circulation published August 2, 2004, doi:10.1161/01.CIR.0000138934.28340.ED
[Abstract]
- Coronary Heart Disease
Clinical and Economic Outcomes of Percutaneous Coronary Interventions in the Elderly: An Analysis of Medicare Claims Data
- Mary Ann Clark, Ameet Bakhai, Michael J. Lacey, Elise M. Pelletier, and David J. Cohen
Circulation 2004;110:259-264; published online before print as doi:10.1161/01.CIR.0000135589.85501.DB
[Abstract]
[Full text]
- Coronary Heart Disease
Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention
- Ronald S. McKechnie, Dean Smith, Cecelia Montoye, Eva Kline-Rogers, Michael J. O’Donnell, Anthony C. DeFranco, William L. Meengs, Richard McNamara, John G. McGinnity, Kirit Patel, David Share, Arthur Riba, Sanjaya Khanal, Mauro Moscucci for the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
Circulation 2004;110:271-277; published online before print as doi:10.1161/01.CIR.0000134964.01697.C7
[Abstract]
[Full text]
- Articles
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses. Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial
- David J. Cohen, Ameet Bakhai, Chunxue Shi, Louise Githiora, Tara Lavelle, Ronna H. Berezin, Martin B. Leon, Jeffrey W. Moses, Joseph P. Carrozza, Jr, James P. Zidar, Richard E. Kuntz on behalf of the SIRIUS Investigators
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000136821.99814.43
[Abstract]
- Editorials
Randomized Clinical Trials: How Long Should They Last?
- Hein J. Wellens
Circulation 2004;110:107-108, doi:10.1161/01.CIR.0000134919.98104.22
[Full text]
- Editorials
The Benefit of Prevention: Engaging the Public Through Strategic Collaborations
- Augustus O. Grant and Alice K. Jacobs
Circulation 2004;109:3062-3063; published online before print as doi:10.1161/01.CIR.0000135141.22757.1E
[Full text]
- Mini-Review: Expert Opinions
Medical Device Development: From Prototype to Regulatory Approval
- Aaron V. Kaplan, Donald S. Baim, John J. Smith, David A. Feigal, Michael Simons, David Jefferys, Thomas J. Fogarty, Richard E. Kuntz, and Martin B. Leon
Circulation 2004;109:3068-3072, doi:10.1161/01.CIR.0000134695.65733.64
[Full text]
- Mini-Review: Expert Opinions
Post-Market Approval Surveillance: A Call for a More Integrated and Comprehensive Approach
- Roxana Mehran, Martin B. Leon, David A. Feigal, David Jefferys, Michael Simons, Nicholas Chronos, Thomas J. Fogarty, Richard E. Kuntz, Donald S. Baim, and Aaron V. Kaplan
Circulation 2004;109:3073-3077, doi:10.1161/01.CIR.0000134694.78653.B6
[Full text]
|
|
